loadpatents
Patent applications and USPTO patent grants for Goergler; Annick.The latest application filed is for "dihydrobenzimidazolones for medical treatment".
Patent | Date |
---|---|
Dihydrobenzimidazolones For Medical Treatment App 20220289738 - Norcross; Roger ;   et al. | 2022-09-15 |
Dihydroquinolinones for medical treatment Grant 11,401,256 - Norcross , et al. August 2, 2 | 2022-08-02 |
Therapeutic Egfr Inhibitors App 20220135571 - Dolente; Cosimo ;   et al. | 2022-05-05 |
Phenoxytriazoles Grant 11,319,314 - Bartels , et al. May 3, 2 | 2022-05-03 |
Egfr Inhibitor For Medical Use App 20220112199 - Dolente; Cosimo ;   et al. | 2022-04-14 |
Dihydrobenzimidazolones for medical treatment Grant 11,254,672 - Norcross , et al. February 22, 2 | 2022-02-22 |
Phenoxytriazoles App 20210309653 - BARTELS; Bjoern ;   et al. | 2021-10-07 |
Compounds App 20210079005 - Duplessis; Martin ;   et al. | 2021-03-18 |
Spirocyclic Compounds App 20210070763 - Nasveschuk; Christopher G. ;   et al. | 2021-03-11 |
Spirocyclic Compounds App 20210032245 - Nasveschuk; Christopher G. ;   et al. | 2021-02-04 |
Dihydroquinolinones For Medical Treatment App 20200207733 - Norcross; Roger ;   et al. | 2020-07-02 |
Glutarimides For Medical Treatment App 20200207783 - Norcross; Roger ;   et al. | 2020-07-02 |
Dihydrobenzimidazolones For Medical Treatment App 20200207764 - Norcross; Roger ;   et al. | 2020-07-02 |
6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives Grant 9,957,261 - Cecere , et al. May 1, 2 | 2018-05-01 |
6-amino-5,6,7,8-tetrahydronaphthalen-2-yl Or 3-aminochroman-7-yl Derivatives App 20170137416 - Cecere; Giuseppe ;   et al. | 2017-05-18 |
Morpholine compounds and uses thereof Grant 9,181,230 - Galley , et al. November 10, 2 | 2015-11-10 |
Morpholine Compounds And Uses Thereof App 20150045359 - Galley; Guido ;   et al. | 2015-02-12 |
4,5-dihydro-oxazol-2yl derivatives Grant 8,729,113 - Galley , et al. May 20, 2 | 2014-05-20 |
Aminomethyl-4-imidazoles Grant 8,586,617 - Galley , et al. November 19, 2 | 2013-11-19 |
2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands Grant 8,389,507 - Galley , et al. March 5, 2 | 2013-03-05 |
2-azetidinemethaneamines And 2-pyrrolidinemethaneamines As Taar-ligands App 20130005988 - Galley; Guido ;   et al. | 2013-01-03 |
4,5-dihydro-oxazol-2YL derivatives Grant 8,242,153 - Galley , et al. August 14, 2 | 2012-08-14 |
4,5-dihydro-oxazol-2yl Derivatives App 20120165294 - Galley; Guido ;   et al. | 2012-06-28 |
4,5-dihydro-oxazol-2yl Derivatives App 20110144333 - Galley; Guido ;   et al. | 2011-06-16 |
4,5-dihydro-oxazol-2yl Derivatives App 20100041686 - Galley; Guido ;   et al. | 2010-02-18 |
4,5-dihydro-oxazol-2yl Derivatives App 20100029589 - Galley; Guido ;   et al. | 2010-02-04 |
2-azetidinemethaneamines And 2-pyrrolidinemethaneamines As Taar-ligands App 20090029962 - Galley; Guido ;   et al. | 2009-01-29 |
Aminomethyl-4-imidazoles App 20080119535 - Galley; Guido ;   et al. | 2008-05-22 |
Malonamide derivatives Grant 7,375,099 - Galley , et al. May 20, 2 | 2008-05-20 |
Aminomethyl-2-imidazoles App 20080096906 - Galley; Guido ;   et al. | 2008-04-24 |
Malonamide derivatives App 20040220222 - Galley, Guido ;   et al. | 2004-11-04 |
1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones Grant 6,599,900 - Cai , et al. July 29, 2 | 2003-07-29 |
1-Oxa-3,9-diaza-spiro[5,5]undecan-2-ones App 20030004163 - Cai, Hai-Ying ;   et al. | 2003-01-02 |
Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation App 20020010174 - Galley, Guido ;   et al. | 2002-01-24 |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor App 20020006932 - Galley, Guido ;   et al. | 2002-01-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.